{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T02:54:41Z","timestamp":1672973681430},"reference-count":0,"publisher":"SAGE Publications","issue":"6 Pt B","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antivir Ther"],"published-print":{"date-parts":[[2012]]},"DOI":"10.3851\/imp2427","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T11:03:50Z","timestamp":1355223830000},"page":"1163-1170","source":"Crossref","is-referenced-by-count":5,"title":["Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?"],"prefix":"10.1177","volume":"17","author":[{"given":"Golo","family":"Ahlenstiel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","container-title":["Antiviral Therapy"],"original-title":[],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T10:51:33Z","timestamp":1629370293000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.intmedpress.com\/journals\/avt\/abstract.cfm?id=2427&pid=88"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":0,"journal-issue":{"issue":"6 Pt B","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.3851\/imp2427","relation":{},"ISSN":["1359-6535"],"issn-type":[{"value":"1359-6535","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}